Search details
1.
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.
CA Cancer J Clin
; 71(1): 78-92, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33002206
2.
Top advances of the year: Ovarian cancer.
Cancer
; 130(6): 837-845, 2024 03 15.
Article
in English
| MEDLINE | ID: mdl-38100616
3.
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Cancer
; 130(6): 936-946, 2024 03 15.
Article
in English
| MEDLINE | ID: mdl-37962093
4.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol
; 186: 104-109, 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38640773
5.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38296517
6.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother
; 72(1): 183-191, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35779095
7.
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
Gynecol Oncol
; 170: 93-101, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36669327
8.
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Gynecol Oncol
; 169: 85-90, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36521353
9.
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.
Gynecol Oncol
; 171: 23-30, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36804618
10.
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Gynecol Oncol
; 173: 130-137, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37148580
11.
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.
Int J Gynecol Cancer
; 2023 Dec 07.
Article
in English
| MEDLINE | ID: mdl-38088180
12.
Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers.
Oncologist
; 27(1): e37-e44, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35305099
13.
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
Gynecol Oncol
; 164(1): 12-17, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34763937
14.
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Gynecol Oncol
; 165(2): 239-247, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35292180
15.
Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer.
Gynecol Oncol
; 161(3): 687-692, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33773807
16.
Non-exenterative surgical management of recurrent endometrial carcinoma.
Gynecol Oncol
; 162(2): 268-276, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34090704
17.
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
Gynecol Oncol
; 163(1): 36-40, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34312001
18.
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 160(1): 51-55, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33213899
19.
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Gynecol Oncol
; 160(1): 71-76, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33139041
20.
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study.
Gynecol Oncol
; 160(3): 696-703, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33386131